News Search

Category: School of Medicine

Penn spinout Verismo Therapeutics Makes Agreement to Fund University Research of KIR-CAR platform of Car-T to Target Solid Tumors

Learn about Penn spinout Verismo Therapeutics' agreement to fund four years of university research of KIR-CAR platform of Car-T to target solid tumors.

Car-T Pioneer Bruce Levine Speaks on the Past, Present and Future of Cancer Therapy

Learn about Dr. Bruce Levine's predictions for the future uses of Car-T therapy.

Gnubiotics and Penn to Explore Car-T Therapy in Combination with Glycopeptides to Target Solid Tumors

This collaboration will take place through company-sponsored pre-clinical research studies in the laboratory of Avery Posey, PhD, an assistant professor at the Perelman School of Medicine.

Five Years of Data Show Long-term Promise for Penn and Novartis’ Car-T Pioneer Kymriah

Five years after Penn and Novartis made history with the FDA approval of Kymriah, a recent study shows the long-term impact of the medication on patient remission rates. 

Penn Partners with PaxeraHealth to Build AI Algorithms for Ultrasound Research

The collaboration between Penn and PaxeraHealth will concentrate on developing imaging algorithms to detect liver cancer in addition to covid detection via lung ultrasounds.

Tribeca Film Festival Documentary Tells the Story of Penn Medicine and Children’s Hospital of Philadelphia’s Path to Cancer Therapy

Penn Medicine and Children’s Hospital of Philadelphia were in the spotlight at the Tribeca Film Festival in New York City, where the documentary “Of Medicine and Miracles" premiered.

COVID Vaccines and Boosters Provoke Robust Immune Response

Several new research studies reported in the New York Times have demonstrated that multiple doses of a COVID vaccine elicit a durable response in most people that protects them from serious illness

Newly discovered ‘encrypted peptides’ with antibiotic properties

A new study reports three distinct proteins in human plasma that have naturally occurring antibiotic properties. Global public health officials are concerned about the r

Decade-long remission after CAR T cell therapy

Two patients represent longest-known CAR T cell response to date, providing insight into treatment effect and outcomes.

The Center for Breakthrough Medicines and Penn partner in the manufacturing of gene therapies

Penn’s Innovation in Process Science combines with CBM manufacturing capability to develop large-scale gene therapy manufacturing capacity, testing, and analytics

Filter

Skip to content